openPR Logo
Press release

Allergic Rhinitis Global Market To Worth USD 15 Billion by 2023 At 7% of CAGR; Declares MRFR

07-30-2019 11:43 AM CET | Health & Medicine

Press release from: Market Research Future

Allergic Rhinitis Global Market To Worth USD 15 Billion by 2023

Allergic Rhinitis, also widely known as hay fever, occurs as an allergic reaction to allergen further causing itchy nose & eyes along with sneezing & a runny nose of course! Pollen is considered as the most common allergen in allergic rhinitis. Besides, Allergic Rhinitis is contagious and it badly affects human respiratory system. Which is why, at the starting of every Allergic Rhinitis season, worldwide governments (especially the Health and Prevention Ministries), as a part of their strategy to provide a comprehensive and integrated health and ensure community wellness, release alert to their respective citizens during the season announcing the recorded cases, the expected ones and the precautionary measures to be taken along with Allergic Rhinitis diagnosis & treatment arrangements.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1547

Allergic Rhinitis spreads easily and hence, is quite prevailing. Attributing to the prevalence of Hay Fever, proliferation of FDA-approved rapid Allergic Rhinitis diagnostic testing methodologies and the recent advances in medical science the market of Allergic Rhinitis is growing pervasively.

Acknowledging the exponential growth the market is perceiving currently and the growth prospects the market is demonstrating globally; Market Research Future (MRFR) recently published a brilliant study report giving out the complete market insights up till 2023. In its report MRFR asserts that the global Allergic Rhinitis market is projected to accrue USD 15 Billion by 2023, registering 7% of CAGR throughout the forecast period (2017 – 2023). Increasing number of patient pool suffering from allergy has spurred the market growth.

In addition, factors that contribute to the market growth include, increasing demand, rapid adoption of various treatments, growing R&D activities, clinical trials, new approvals among others. Companies, active in the market are increasingly collaborating with hospitals and independent research centers to develop new treatments, which in turn is driving the market growth. Simultaneously, augmenting uptake of Allergic Rhinitis treatments among medical professionals as well as patients, along with the growing awareness towards benefits of the treatments, and increasing success rate are some of the important factors for the market growth.

Conversely, factors such as incidents of diagnostic products resistance/allergies and unmet clinical needs, are expected to restrict the market growth of Allergic Rhinitis. However advancements in biotechnology coupled with the planned Government initiatives are expected to fuel the global Allergic Rhinitis market.

Bilirubin Blood Test Global Market – Competitive Analysis

The market of Bilirubin Blood Test appears to be fiercely competitive & fragmented owing to the presence of numerous matured & small key players accounting for a substantial market share. These market players try to gain competitive advantage through strategic partnership, acquisition, expansion, collaboration, product & technology launch. They invest heavily in the R&D to develop a technology that is completely on a different level compared to their competition.

Top Key Players
GSK (UK), Merck (US), Sanofi (France), Himalaya (India), Cigna (USA), J&J (US), FaesFarma (Spain), Chong Kun Dang Pharmaceutical Corp. (South Korea), Glenmark Pharmaceutical (India), Ampio pharmaceutical Inc. (US), Olain Farm (Lavtvia) and Hisamitsu Pharmaceutical Co.in (Japan) are some of the leaders driving the Global Allergic Rhinitis Market. Profiling those in its analysis MRFR finds out their strategies placing them at the forefront of completion.

Worldwide Allergic Rhinitis Market - Segmentation

Global Allergic Rhinitis Market is segmented in to 4 Key dynamics for an easy grasp and enhanced understanding.

By Type : Comprises - Seasonal, Perennial & Non allergic rhinitis.

By Treatment : Antihistamines (allegra, clarinex, xyzal & zyrtec), Decongestants (afrin nasal spray, sudafed, sudafed PE and zyrtec-D), Eye drops, Nasal sprays & others (immunotherapy, sublingual immunotherapy (SLIT) & home remedies)

By Type : Comprises - Seasonal, Perennial & Non allergic rhinitis.

By Regions : North America, Europe, APAC and Rest of the World.

Read Complete Report @ https://www.marketresearchfuture.com/reports/allergic-rhinitis-market-1547

Worldwide Allergic Rhinitis Market - Geographical Analysis

North America market leads the global Allergic Rhinitis market with the significant market share. The market is further expected to reach astronomical amounts growing at a substantial CAGR throughout the forecast period (2017-2023). Well-developed healthcare sector and increasing prevalence of hay fever coupled with the high per capita healthcare expenditures drive the regional market growth.

Europe & Asia Pacific is the second & third largest market for Allergic Rhinitis, respectively. Expected to be a fastest growing market Asia pacific region is estimated to grow rapidly over the projected period. Growing population, increasing healthcare expenditures & rising incidence of allergic rhinitis, along with the greater awareness about this disease and its treatment propel the APAC market.

Industry, Innovation & Related News
February 26, 2018 – Han Wha Pharma (South Korea) announced the availability of its new medicine, a nasal bacteria protective cream – Rhino-Protect PRS, developed by Dr. Theiss (Germany) to prevent the inhalation of allergens. FDA, US approved as Grade 2 medical device, the said product can work against various allergens, including pollens. Rhino-Protect PRS contains no steroids, antibiotics, antihistamines, or preservatives & has no side effects. The product can be an alternative for the patients of allergic rhinitis, who have adverse reactions to steroids or suffer from antihistamine’s side effects such as drowsiness.

February 16, 2018 – Stallergenes Greer Plc. (UK) announced receiving approval for sale in Japan, for one of its breakthrough products - ACTAIR® for paediatric use. ACTAIR is a sublingual immunotherapy tablet for the treatment of house dust mite allergy.

February 28, 2018 – Innovus Pharmaceuticals, Inc. (US) announced receiving Commercial Approval by Health Canada for its Natural Health Product - AllerVarx™. The medicine is effective in reducing symptoms of seasonal Allergic Rhinitis.

Get Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/1547

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Allergic Rhinitis Global Market To Worth USD 15 Billion by 2023 At 7% of CAGR; Declares MRFR here

News-ID: 1814441 • Views:

More Releases from Market Research Future

9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through 2035
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years. Market Overview and Size The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends. Get Sample @ https://www.marketresearchfuture.com/sample_request/41217 Market Size and Growth The global washable
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR by 2032
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview: The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical

All 5 Releases


More Releases for Allergic

Prominent Allergic Rhinitis Market Trend for 2025: Advancements In Treating Nasa …
Which drivers are expected to have the greatest impact on the over the allergic rhinitis market's growth? Anticipated growth in the allergic rhinitis market is predicted to be driven by increasing levels of air pollution and the impact of climate change. The term air pollution denotes the existence of harmful substances in our planet's atmosphere, which can negatively impact human health, damage the environment, and reduce the air's quality. Climate change
Allergic Rhinitis: A Comprehensive Overview
Allergic rhinitis, commonly known as hay fever, is a condition where an individual's immune system overreacts to allergens in the air. These allergens, which may include pollen, dust, or pet dander, trigger inflammation inside the nose, leading to symptoms like sneezing, a runny nose, itchy eyes, and congestion. While often associated with the spring and fall seasons due to pollen levels, allergic rhinitis can affect individuals year-round, depending on the
Allergic Conjunctivitis Market Statistics, Growth | Forecast
The new report published by The Business Research Company, titled ""Allergy Conjunctivitis Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the allergy conjunctivitis market size has grown strongly in recent years. It will grow from $2.4 billion in 2023
Anti-Allergic Drugs Market Overview 2030
Anti-allergic drugs represent a pivotal domain in healthcare, providing advanced solutions to alleviate symptoms triggered by allergens. With an ever-growing prevalence of allergies globally, the anti-allergic drugs market is witnessing a significant surge. Valued at USD 26,234 Million in 2021, the market is poised to skyrocket to USD 47,566 Million by 2030, showcasing a robust CAGR of 6.8%. In the United States alone, where allergies affect 40 to 50 million
Allergic Conjunctivitis Market - Clear Eyes, Allergy-Free: Allergic Conjunctivit …
Newark, New Castle, USA: The "Allergic Conjunctivitis Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Allergic Conjunctivitis Market: https://www.growthplusreports.com/report/allergic-conjunctivitis-market/7892 This latest report researches the industry structure, sales, revenue,
Allergic Conjunctivitis Market - Empowering Eyes, Enhancing Lives: Redefining Al …
Newark, New Castle, USA - new report, titled Allergic Conjunctivitis Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Allergic Conjunctivitis market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Allergic Conjunctivitis market. The report offers an overview of the market, which